Immuno-PCR: a promising ultrasensitive diagnostic method to detect antigens and antibodies

Nada Malou1, Didier Raoult

  • 1URMITE CNRS/IRD 6236, Faculté de médecine, Université de la Méditerranée, Marseille, 13385, France.

Trends in Microbiology
|April 12, 2011
PubMed

Insights

Immuno-PCR (iPCR) combines ELISA and PCR for sensitive protein detection. Recent advancements are making iPCR a viable and routine tool for microbial diagnostics.

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Immuno-PCR (iPCR) merges ELISA and PCR, offering high sensitivity for protein antigen detection.
  • Historically, iPCR has been underutilized due to limitations, reflected in sparse publication records.
  • The development of novel systems and reagents is enhancing iPCR's applicability.

Purpose of the Study:

  • To review the evolution of Immuno-PCR (iPCR) technology.
  • To highlight the advancements that address previous drawbacks of iPCR.
  • To explore the potential of iPCR as a routine microbial diagnostic tool.

Main Methods:

  • Review of classical and modern Immuno-PCR (iPCR) formats.
  • Analysis of technological improvements in iPCR systems.
  • Evaluation of iPCR's suitability for microbial diagnostics.

Main Results:

  • Early iPCR formats presented significant drawbacks hindering routine use.
  • Modern iPCR systems incorporate ready-to-use reagents and diverse linker molecules.
  • Protocol times have been reduced, and new systems enhance iPCR's practicality.

Conclusions:

  • Immuno-PCR (iPCR) has evolved from a niche technique to a promising diagnostic method.
  • Technological refinements are overcoming previous limitations of iPCR.
  • iPCR is poised to become an essential tool in microbial diagnostics.